Summary
Cardio-facio-cutaneous (CFC) syndrome is a rare genetic disorder that affects the heart, facial features, skin, hair, and overall development. Children with CFC syndrome may present with a wide range of symptoms, including congenital heart disease, distinctive craniofacial appearance, dermatologic abnormalities, feeding issues, and developmental delays. The condition results from variations in genes that regulate cell growth and signaling pathways. While there is no cure, multidisciplinary medical care and therapies can significantly improve quality of life and outcomes.
Description
CFC syndrome is part of a group of conditions called RASopathies, which are caused by problems in the RAS/MAPK pathway—a system that controls how cells grow and divide. In healthy individuals, this pathway helps regulate normal growth, learning, and organ development. In CFC syndrome, variations in genes like BRAF, MAP2K1, MAP2K2, or KRAS disrupt this process.
Most cases arise sporadically (de novo) and are not inherited, though rare autosomal dominant familial cases have been reported (meaning it can sometimes be inherited and run in families). Clinical severity varies by organ involvement. CFC is generally compatible with long-term survival, though complications from congenital heart disease or recurrent infections may be life-threatening if untreated.
Signs and Symptoms
Diagnosis is based on genetic testing and clinical features. Common signs and symptoms include:
- Heart defects (up to 75%): Pulmonary valve stenosis, atrial septal defect, hypertrophic cardiomyopathy
- Distinctive facial features: High forehead, wide-set eyes, short nose, low-set ears, and a prominent forehead
- Skin and hair changes: Dry, rough skin; sparse, curly, or brittle hair; eczema; birthmarks
- Developmental delays: Speech and motor delays, intellectual disability (mild to moderate)
- Feeding difficulties: Poor sucking, reflux, or trouble gaining weight in infancy
- Short stature
- Other features: Seizures, vision problems (strabismus, ptosis), hearing loss, joint laxity, and skeletal differences
Symptoms may be subtle in early infancy, such as feeding problems or mild facial differences. Over time, developmental and physical features become more noticeable. Some children may have more severe heart or neurological issues.
Causes
CFC is caused by activating mutations in genes of the RAS/MAPK pathway: most commonly BRAF, followed by MAP2K1, MAP2K2, and KRAS.
- Inheritance: Typically de novo, but rare vertical transmission occurs (autosomal dominant) (meaning it is rarely passed from a parent to a child).
- Environmental factors: None identified. There is no known parental behavior during pregnancy that increases risk.
Laboratory Investigations
To diagnose and monitor CFC syndrome, doctors may use:
- Genetic testing: To identify mutations in the BRAF, MAP2K1, MAP2K2, or KRAS genes
- Echocardiogram (heart ultrasound): To check for heart defects
- Physical exam: To assess growth, facial features, skin, and joints
- Developmental assessments: To measure learning, speech, and motor skills
- Eye and hearing tests: To check for vision or hearing problems
- Brain MRI or EEG: If seizures or neurological symptoms are present
These tests are usually done at diagnosis, but some (like heart or developmental assessments) may be repeated over time to monitor changes.
Treatment and Therapies
There is no cure for CFC syndrome, but treatment focuses on managing symptoms:
- Heart surgery or medications: For heart defects
- Physical, occupational, and speech therapy: To help with movement, daily skills, and communication
- Feeding support: Including feeding tubes if needed for severe feeding problems
- Dermatology care: For skin and hair issues
- Seizure management: Anti-seizure medications if necessary
- Vision and hearing care: Glasses, hearing aids, or surgery if needed
- Special education and behavioral therapy: For learning and developmental challenges
Treatment plans are personalized for each child. Some therapies or medications may have side effects like tiredness or stomach upset. Without treatment, problems like heart failure or malnutrition may become life-threatening. Most people need lifelong support from a team of specialists.
Outlook
The outlook for people with CFC syndrome depends on the severity of symptoms, especially heart defects. With proper medical care, many children survive into adulthood, but most will have ongoing health and developmental challenges. Independence as adults is rare for those with moderate to severe disabilities. Most will need special education and therapy services. The disorder affects daily life, school, and family routines. Diet and exercise do not cure CFC syndrome, but a healthy lifestyle supports overall well-being. Families may need to adjust routines and seek support from therapists, teachers, and community resources.
Resources
The links and resources included in this section are solicited directly from the community by the Child Neurology Foundation through a formal submission process. CNF reserves the right to remove entities at any time if information is deemed inappropriate or inconsistent with the mission, vision, and values of CNF. The authors listed on this page have not endorsed the resources or links provided in this section.
Our Mission
To improve the quality of life for individuals with Cardiofaciocutaneous syndrome and their families through support, research, awareness and education.
OUR VISION
To advance understanding and treatment of CFC syndrome.
Research
ClinicalTrials.gov for Cardio-Facio-Cutaneous Syndrome (birth to 17 years)
These are clinical trials that are recruiting or will be recruiting. Updates are made daily, so you are encouraged to check back frequently.
ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. This is a resource provided by the U.S. National Library of Medicine (NLM), which is an institute within the National Institutes of Health (NIH). Listing a study does not mean it has been evaluated by the U.S. Federal Government. Please read the NLM disclaimer for details.
Before participating in a study, you are encouraged to talk to your health care provider and learn about the risks and potential benefits.
For more information about participation in clinical trials, check out our education hub on the topic here.
The information in the CNF Child Neurology Disorder Directory is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. Content provided is for informational purposes only. CNF is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options.
References
- National Organization for Rare Disorders. Cardiofaciocutaneous syndrome [Internet]. Danbury (CT): NORD; 2023 [cited 2025 Jul 11]. Available from: https://rarediseases.org/rare-diseases/cardiofaciocutaneous-syndrome/
- Allanson JE, Roberts AE. Cardiofaciocutaneous Syndrome. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024 [updated 2022 Mar 17; cited 2025 Jul 11]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1186/
- Rauen KA. Cardio-facio-cutaneous syndrome. In: Orphanet Journal of Rare Diseases. 2007;2:33. doi:10.1186/1750-1172-2-33. PMID: 17961228; PMCID: PMC2098772.
- Genetics Home Reference. Cardiofaciocutaneous syndrome [Internet]. Bethesda (MD): National Institutes of Health; [cited 2025 Jul 11]. Available from: https://ghr.nlm.nih.gov/condition/cardiofaciocutaneous-syndrome
- CFC International. What is CFC syndrome? [Internet]. 2024 [cited 2025 Jul 11]. Available from: https://www.cfcsyndrome.org/about-cfc-syndrome/
- Perplexity AI, Inc. Perplexity [Internet]. San Francisco (CA): Perplexity AI, Inc.; 2025 [cited 2025 Oct 24]. Available from: https://www.perplexity.ai
This overview is for general information and is not a substitute for advice from your child's care team.
← Back to the Disorder Directory